688389 fundamentals

Key facts

Market capitalization‪6.51 B‬CNY
Founded2008
CEOMing Long Hu
About

Shenzhen Lifotronic Technology Co., Ltd. engages in the research, development, production, sales of treatment and rehabilitation products. Its products include vitro diagnostic equipment, HPLC, ECLIA, hematology, POCT, molecular diagnostics, rapid test, respiratory & ICU wound care, ESWT pain management, laser hair removal, profirm HIFU, megapower IPL, and fractional CO2 laser system. The company was founded by Lei Yu Xiang, Xiao Fang Liu and Xian Cheng Liu on January 16, 2008 and is headquartered in Shenzhen, China.

Ownership
‪‪428.49 M‬‬
Closely held shares
‪‪241.18 M‬‬ (56.29%)
Free Float shares
‪‪187.30 M‬‬ (43.71%)
Closely held shares
‪‪241.18 M‬‬ (56.29%)
Free Float shares
‪‪187.30 M‬‬ (43.71%)
Capital structure
Market cap
‪‪6.51 B‬‬
Enterprise value
‪‪6.51 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪6.51 B‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
‪0.00‬
‪2.20‬
‪4.40‬
‪6.60‬
‪8.80‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪8.00‬
‪16.00‬
‪24.00‬
‪32.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪20%‬
‪25%‬
‪30%‬
‪35%‬
‪40%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪90.00 M‬‬
‪‪180.00 M‬‬
‪‪270.00 M‬‬
‪‪360.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−300.00 M‬‬
‪‪−150.00 M‬‬
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−300.00 M‬‬
‪‪−150.00 M‬‬
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
In Vitro Diagnostics - Test Reagent
In Vitro Diagnostics - Inspection Equipment
Treatment and Rehabilitation - Medical Products
Treatment and Rehabilitation - Household Products
Other Business
By country
Period: 2024
China
Foreign

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪80.00 M‬‬
‪‪160.00 M‬‬
‪‪240.00 M‬‬
‪‪320.00 M‬‬
Actual
Earnings
Next:Apr 25, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪0.10‬
‪0.20‬
‪0.30‬
‪0.40‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
0.00%
Payout ratio (TTM)
Dividend yield TTM
1.83%
Last payment
0.281
Last ex-date
May 6, 2024
Dividend history
‪0.75%‬
‪0.90%‬
‪1.05%‬
‪1.20%‬
‪1.35%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.08‬
‪0.16‬
‪0.24‬
‪0.32‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪500.00 M‬‬
‪‪1.00 B‬‬
‪‪1.50 B‬‬
‪‪2.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.